- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/345 - Nitrofurans
Patent holdings for IPC class A61K 31/345
Total number of patents in this class: 76
10-year publication summary
|
6
|
2
|
8
|
4
|
2
|
9
|
3
|
8
|
8
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DSM IP Assets B.V. | 5568 |
3 |
| Bharat Biotech International Limited | 94 |
3 |
| Centre National de La Recherche Scientifique | 10128 |
2 |
| The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | 113 |
2 |
| The Penn State Research Foundation | 1475 |
2 |
| Nanjing Shijiang Medicine Technology Co., Ltd | 25 |
2 |
| The Regents of the University of California | 19625 |
1 |
| AstraZeneca AB | 2940 |
1 |
| AstraZeneca UK Limited | 673 |
1 |
| Boehringer Ingelheim International GmbH | 4726 |
1 |
| The Johns Hopkins University | 5554 |
1 |
| President and Fellows of Harvard College | 5900 |
1 |
| Academisch Ziekenhuis Groningen | 110 |
1 |
| Acies Bio d.o.o. | 33 |
1 |
| Akebia Therapeutics, Inc. | 114 |
1 |
| Akita University | 94 |
1 |
| Association Francaise Contre Les Myopathies (afm) | 9 |
1 |
| British Columbia Cancer Agency Branch | 194 |
1 |
| Brown University | 634 |
1 |
| Chelsea Therapeutics, Inc. | 17 |
1 |
| Other owners | 48 |